Aug 2026· Frontiers in Medicine· Vol 13· 1 citation· 40 references
Medicine
TL;DR
Blood biomarker profiles could represent diagnostic biomarkers for ILD in RA and were increased and those of C-C motif chemokine ligand (CCL)3 were decreased in RA with ILD compared with those without CLD.
Abstract
Objective The prognosis of patients with rheumatoid arthritis (RA) complicated with interstitial lung disease (ILD) is very poor. We used blood protein profiles to identify biomarkers for ILD in patients with RA. Methods Proteome analyses of plasma samples from 16 RA patients with ILD or without chronic lung disease (CLD) were performed with a proteomic assay using antibody immunoassay and next generation sequencing. Validation of the results was achieved by multiplex bead-based immunoassay of 20 candidate protein biomarkers in serum of 96 RA patients with ILD or without CLD. Results Levels of carbohydrate antigen 125 (CA125), C-X-C motif chemokine ligand (CXCL)9, CXCL13, interleukin (IL)-19, tissue inhibitor of metalloproteinase (TIMP)-1, TIMP-2, and TIMP-4 were increased and those of C-C motif chemokine ligand (CCL)3 were decreased in RA with ILD compared with those without CLD. Multiple logistic regression analysis of CXCL9, CXCL13, and TIMP-1 was performed to generate an ILD-index. The area under the curve value of receiver operating characteristic curve of ILD-index was 0.818 (95% confidence interval 0.730–0.907). Conclusions Blood biomarker profiles could represent diagnostic biomarkers for ILD in RA.
Background/Aims: Monitoring endoscopic inflammation in Crohn’s disease (CD) is difficult. This study examined whether X-C motif chemokine ligand 1 (XCL1) is associated with endoscopic activity, as defined by the Simple Endoscopic Score for Crohn’s Disease (SES-CD).
Materials and Methods: This was a single-center obser...
Zhen Li, Yan-Ping Hao, Jin Chen et al.· The Turkish Journal of Gastr...· 0 citations
Introduction Tuberculosis remains a major global health challenge, with many patients expe- riencing unfavourable treatment outcomes despite standard therapy. Host immune biomarkers, including cytokines, chemokines, and matrix metalloproteinases (MMPs), have shown promise in predicting disease severity and treatment re...
Agalya Vanamudhu, V. Viswanathan, Guruprashath Mohan et al.· Frontiers in Immunology· 0 citations
Rheumatoid arthritis (RA) is characterized by chronic inflammatory polyarthritis. Despite recent advances in treatment, a subset of patients remains refractory, highlighting the need for better biomarkers for diagnosis and disease activity monitoring to determine appropriate interventions. Therefore, this study aimed t...
M. Kanaji, J. Nishio, Mayuko Oka et al.· Immunological Medicine· 0 citations
Introduction Elevated C-reactive protein (CRP) is a hallmark of rheumatoid arthritis (RA) flares. CRP exists as pentameric (pCRP) and monomeric (mCRP) isoforms with distinct functions, with pCRP generally pro-inflammatory and mCRP more immunomodulatory. Standard clinical assays do not distinguish between these forms, a...
Alexia Correia Ferreira, L. Martin-Gutierrez, C. Lalaurie et al.· Frontiers in Immunology· 0 citations
It is suggested that serum pyrin demonstrates promising diagnostic accuracy for distinguishing RA patients from healthy individuals, and pyrin uniquely correlated with disease activity (DAS28-ESR), suggesting a complementary role as a disease activity-reflective biomarker rather than a purely diagnostic marker.
Amjad Aziz Talib, Khawla A. Shemran, Zakaria Moayad Baqer· Indian Journal of Rheumatolo...· 0 citations
The implementation of refined management of systemic lupus erythematosus (SLE) poses a considerable challenge in clinical practice. In this study, we evaluated serum stromal cell-derived factor 4 (SDF4) as potential biomarkers for SLE diagnosis, disease severity, and prognosis.
We determined the SDF4 level...
Xi Chen, Xuan-Zhe Yang, Jing Chen et al.· BMC Immunology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.